HealthInvest Partners AB - Q4 2022 holdings

$51.8 Million is the total value of HealthInvest Partners AB's 53 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 470.0% .

 Value Shares↓ Weighting
UTMD BuyUTAH MED PRODS INC$9,449,820
+28.8%
94,000
+9.3%
18.25%
+17.7%
CAH BuyCARDINAL HEALTH INC$7,687,000
+64.7%
100,000
+42.9%
14.84%
+50.5%
CI SellCIGNA CORP NEW$5,301,440
+12.4%
16,000
-5.9%
10.24%
+2.7%
VTRS SellVIATRIS INC$5,286,750
+29.3%
475,000
-1.0%
10.21%
+18.2%
NewGSK PLCsponsored adr$5,271,000150,000
+100.0%
10.18%
GILD SellGILEAD SCIENCES INC$5,216,246
-19.5%
60,760
-42.1%
10.07%
-26.4%
CVS NewCVS HEALTH CORP$4,845,88052,000
+100.0%
9.36%
BMY SellBRISTOL-MYERS SQUIBB CO$4,676,750
-32.9%
65,000
-33.7%
9.03%
-38.6%
KMPH SellKEMPHARM INC$1,514,700
-67.6%
330,000
-56.0%
2.92%
-70.4%
AUPH  AURINIA PHARMACEUTICALS INC$993,600
-42.6%
230,0000.0%1.92%
-47.5%
UNH NewUNITEDHEALTH GROUP INC$200,938379
+100.0%
0.39%
ABBV NewABBVIE INC$131,066811
+100.0%
0.25%
MRK NewMERCK & CO INC$123,1551,110
+100.0%
0.24%
LLY NewLILLY ELI & CO$122,556335
+100.0%
0.24%
TMO NewTHERMO FISHER SCIENTIFIC INC$121,152220
+100.0%
0.23%
REGN NewREGENERON PHARMACEUTICALS$67,09993
+100.0%
0.13%
PFE NewPFIZER INC$62,5131,220
+100.0%
0.12%
VRTX NewVERTEX PHARMACEUTICALS INC$62,376216
+100.0%
0.12%
ABC NewAMERISOURCEBERGEN CORP$51,204309
+100.0%
0.10%
BSX NewBOSTON SCIENTIFIC CORP$49,0921,061
+100.0%
0.10%
SYK NewSTRYKER CORPORATION$48,409198
+100.0%
0.09%
IQV NewIQVIA HLDGS INC$44,051215
+100.0%
0.08%
BMRN NewBIOMARIN PHARMACEUTICAL INC$42,845414
+100.0%
0.08%
DXCM NewDEXCOM INC$33,859299
+100.0%
0.06%
MRNA NewMODERNA INC$33,589187
+100.0%
0.06%
RPRX NewROYALTY PHARMA PLC$31,260791
+100.0%
0.06%
EW NewEDWARDS LIFESCIENCES CORP$26,561356
+100.0%
0.05%
NBIX NewNEUROCRINE BIOSCIENCES INC$22,216186
+100.0%
0.04%
MASI NewMASIMO CORP$22,488152
+100.0%
0.04%
OPCH NewOPTION CARE HEALTH INC$22,146736
+100.0%
0.04%
ALNY NewALNYLAM PHARMACEUTICALS INC$22,10193
+100.0%
0.04%
CYTK NewCYTOKINETICS INC$20,161440
+100.0%
0.04%
ITCI NewINTRA-CELLULAR THERAPIES INC$15,453292
+100.0%
0.03%
DOCS NewDOXIMITY INCcl a$15,505462
+100.0%
0.03%
RXDX NewPROMETHEUS BIOSCIENCES INC$13,420122
+100.0%
0.03%
EXAS NewEXACT SCIENCES CORP$13,269268
+100.0%
0.03%
INSP NewINSPIRE MED SYS INC$13,09852
+100.0%
0.02%
KRYS NewKRYSTAL BIOTECH INC$11,012139
+100.0%
0.02%
AKRO NewAKERO THERAPEUTICS INC$9,097166
+100.0%
0.02%
BLU NewBELLUS HEALTH INC NEW$8,8371,075
+100.0%
0.02%
OM NewOUTSET MED INC$8,882344
+100.0%
0.02%
PRTA NewPROTHENA CORP PLC$7,893131
+100.0%
0.02%
MRVI NewMARAVAI LIFESCIENCES HLDGS I$6,797475
+100.0%
0.01%
BCYC NewBICYCLE THERAPEUTICS PLCsponsored adr$6,690226
+100.0%
0.01%
SWAV NewSHOCKWAVE MED INC$6,58032
+100.0%
0.01%
FOLD NewAMICUS THERAPEUTICS INC$6,764554
+100.0%
0.01%
KRTX NewKARUNA THERAPEUTICS INC$6,68134
+100.0%
0.01%
BBIO NewBRIDGEBIO PHARMA INC$6,759887
+100.0%
0.01%
IMGN NewIMUNOGEN INC$6,4481,300
+100.0%
0.01%
PSTX NewPOSEIDA THERAPEUTICS INC$5,6661,069
+100.0%
0.01%
MRUS NewMERUS N V$4,424286
+100.0%
0.01%
NewARCELLX INC$4,399142
+100.0%
0.01%
DNLI NewDENALI THERAPEUTICS INC$4,394158
+100.0%
0.01%
OPNT ExitOPIANT PHARMACEUTICALS INC$0-210,000
-100.0%
-4.77%
MCK ExitMCKESSON CORP$0-13,000
-100.0%
-9.33%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARLES RIV LABS INTL INC17Q4 201712.8%
GILEAD SCIENCES INC16Q4 202214.5%
CARDINAL HEALTH INC15Q4 202214.8%
IMMUCELL CORP15Q2 20171.7%
MCKESSON CORP14Q3 202214.6%
ANTHEM INC12Q4 201714.3%
TRIPLE-S MGMT CORP12Q4 20168.7%
LIFEPOINT HOSPITALS INC11Q2 201613.3%
SUPERNUS PHARMACEUTICALS INC10Q3 202115.5%
ANIKA THERAPEUTICS INC10Q4 201713.0%

View HealthInvest Partners AB's complete holdings history.

Latest significant ownerships (13-D/G)
HealthInvest Partners AB Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVAMED INCMarch 03, 2011405,8755.1%
THERAGENICS CORPFebruary 11, 20093,322,8469.9%
BIO IMAGING TECHNOLOGIES INCJanuary 09, 2009766,4255.3%
ALLION HEALTHCARE INCJuly 07, 2008887,2554.6%
SONIC INNOVATIONS INCJune 26, 20081,328,2014.9%
CANDELA CORP /DE/June 06, 2008697,1643.1%
INTEGRAMED AMERICA INCJune 02, 20082,2000.0%
AFP IMAGING CORPFebruary 04, 200827,5200.2%
OPHTHALMIC IMAGING SYSTEMSDecember 28, 2007834,4404.9%
ANGEION CORP/MNOctober 16, 2007196,0244.8%

View HealthInvest Partners AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-30
13F-HR2023-02-14
13F-HR2022-10-21
13F-HR2022-07-08
13F-HR2022-05-05
13F-HR2022-01-18
13F-HR2021-11-08
13F-HR2021-08-10
13F-HR2021-04-30

View HealthInvest Partners AB's complete filings history.

Compare quarters

Export HealthInvest Partners AB's holdings